UGUSTA, Ga. (Dec. 6, 2017) – In an exciting breakthrough scientists have discovered that a common pain medication often prescribed for chronic pain can help preserve vision in a model of severe, blinding retinal degeneration. The vision preservation could activate one of the most powerful antioxidants in the human body known as Nrf2. This targets… Continue reading Augusta University Discovers How Nrf2 Activator Preserves Sight in Retinal Degeneration Model
Tag: Parkinson’s disease
Review: Nrf2, a multi-organ protector?
A classic NRF2 study entitled, “Nrf2, a multi-organ protector?” predates many of the latest studies regarding NRF2. It was however one of those landmark studies that paved the way for later studies. The study states, “Nrf2 may serve as a master regulator of the ARE-driven cellular defense system against oxidative stress.” and then goes on… Continue reading Review: Nrf2, a multi-organ protector?
Michael J. Fox Foundation Awards an Additional Grant for Nrf2 Research
Our original article highlighting the Michael J. Fox Foundation’s interest in NRF2 activation solutions for Parkinson’s disease met with a lot of interest, so we decided to do a follow up piece highlighting an additional study that is currently underway. This time, the Michael J. Fox Foundation has provided a grant in its search for… Continue reading Michael J. Fox Foundation Awards an Additional Grant for Nrf2 Research